Rare diseases
Investigational molecules
Locations
Back to Ireland324 clinical trials in Drogheda, Ireland. Every trial is listed in the EU Clinical Trials Register and updated daily.
Study on Abatacept for Improving Recovery in Hospitalized COVID-19 Patients
IrelandStudy on the Effects of Psilocybin (COMP360) for Adults with Treatment-Resistant Depression
IrelandStudy of Inotuzumab Ozogamicin Alone and with Drug Combination for Children with Relapsed or Refractory Acute Lymphoblastic Leukemia
IrelandStudy of Belzutifan and Pembrolizumab for Patients with Renal Cell Carcinoma After Surgery
IrelandStudy Comparing Integrase Inhibitor (Bictegravir) and Boosted Protease Inhibitor (Darunavir) Treatments for Patients with Advanced HIV Infection
IrelandStudy Comparing Zimberelimab and Domvanalimab with Pembrolizumab for Patients with Advanced Non-Small Cell Lung Cancer
IrelandStudy of pembrolizumab with gemcitabine and cisplatin as first treatment for patients with advanced or inoperable bile duct cancer
IrelandStudy on Larotrectinib for Treating Children with Advanced Solid Tumors with NTRK Fusion
IrelandStudy on the Safety and Effectiveness of Telisotuzumab Vedotin for Patients with Previously Treated c-Met Positive Non-Small Cell Lung Cancer
IrelandStudy of Trastuzumab Deruxtecan for Patients with Unresectable or Metastatic HER2-low or HER2 IHC0 Breast Cancer
IrelandStudy of Adagrasib and Cetuximab for Patients with Advanced Colorectal Cancer with KRAS G12C Mutation After First-Line Therapy
IrelandStudy of Pembrolizumab, Trastuzumab, and Chemotherapy for Patients with HER2 Positive Advanced Stomach or Gastroesophageal Junction Cancer
IrelandThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on inflammatory bowel diseases, including trials evaluating new therapeutic approaches for ulcerative colitis and Crohn's disease. Studies are examining novel compounds like obefazimod for improving patient outcomes.
Multiple trials are investigating endoscopic improvement and symptomatic remission in patients with moderate to severe conditions.
Groundbreaking research in preventing and treating various infections, with particular focus on Clostridioides difficile infection recurrence and surgical site infections following abdominal procedures.
Studies are evaluating novel preventive measures and treatment approaches to reduce infection rates.
Clinical research examining treatments for chronic skin conditions, with emphasis on Hidradenitis Suppurativa. Trials are evaluating new biological therapies like lutikizumab for moderate to severe cases.
Research focuses on improving symptoms and quality of life for patients with persistent skin disorders.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
